Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis

Immune checkpoint inhibitors (ICIs) are now widely used to many malignant diseases, but some patients suffer from immune-related adverse events during or after ICI treatments. The monoclonal antibody infliximab is usually chosen as a salvage treatment to combat corticosteroid-resistant adverse event...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oxf Med Case Reports
Main Authors: Nakano, Kenji, Nishizawa, Masatoshi, Fukuda, Naoki, Urasaki, Tetsuya, Wang, Xiaofei, Mitani, Hiroki, Takahashi, Shunji
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243717/
https://ncbi.nlm.nih.gov/pubmed/32477577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omaa027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados